What is the generic name?

WARFARIN SODIUM

What is the Trade Name for WARFARIN SODIUM?

COUMADIN

What are the Indications for WARFARIN SODIUM?

• 1 INDICATIONS AND USAGE COUMADIN ¬Æ is indicated for: ‚Ä¢ Prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (PE). ‚Ä¢ Prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation (AF) and/or cardiac valve replacement. ‚Ä¢ Reduction in the risk of death, recurrent myocardial infarction (MI), and thromboembolic events such as stroke or systemic embolization after myocardial infarction. Limitations of Use COUMADIN has no direct effect on an established thrombus, nor does it reverse ischemic tissue damage. Once a thrombus has occurred, however, the goals of anticoagulant treatment are to prevent further extension of the formed clot and to prevent secondary thromboembolic complications that may result in serious and possibly fatal sequelae. COUMADIN is a vitamin K antagonist indicated for: ‚Ä¢ Prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (1) ‚Ä¢ Prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement (1) ‚Ä¢ Reduction in the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction (1) Limitations of Use COUMADIN has no direct effect on an established thrombus, nor does it reverse ischemic tissue damage. (1)

References: https://open.fda.gov/